HTGM News and Press, HTG Molecular Diagnostics Inc. From 05/09/19

HTG Molecular Diagnostics, Inc. (HTGM) Q1 2019 Earnings Conference Call May 9, 2019 4:30 P.M. ET Company Participants Monique Kosse - Investor Relations John Lubniewski - Chief Executive Officer Shaun McMeans - Chief Financial Officer Conference Call Participants Jordan Abr...

HTG Molecular (NASDAQ: HTGM ): Q1 GAAP EPS of -$0.19 beats by $0.02 . More news on: HTG Molecular Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

TUCSON, Ariz., May 09, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today reported its financial results for the first quarter ended March 31, 2019. Recent Accomplishments & High...

TUCSON, Ariz., April 30, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial results for the first quarter ended March 31, 2019 after the market clos...

Thinly traded nano cap HTG Molecular Diagnostics (NASDAQ: HTGM ) has amended its IVD Test Development and Component Supply Agreement with Illumina (NASDAQ: ILMN ) to enable the expansion of IVD test development and commercialization for HTG EdgeSeq and ILMN sequencing technology. More ne...

Amendment allows for the development of IVD test kits compatible with Illumina technology TUCSON, Ariz., April 30, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it ha...

TUCSON, Ariz., March 27, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has released a new HTG EdgeSeq Mouse mRNA Tumor Response Panel available now in the United States...

HTG Molecular Diagnostics (NASDAQ: HTGM ) has slipped 3.9% postmarket after an SEC filing notes it's entered into a share sales agreement with Cowen and Co. More news on: HTG Molecular Diagnostics, Inc., Healthcare stocks news, Stocks on the move, Read more ...

HTG Molecular Diagnostics, Inc. (HTGM) Q4 2018 Results Earnings Conference Call March 07, 2019 04:30 PM ET Company Participants Monique Kosse - Investor Relations TJ Johnson - Chief Executive Officer John Lubniewski - President, Chief Operating Officer Shaun McMeans - Chief Fin...

The following slide deck was published by HTG Molecular Diagnostics, Inc. in conjunction with this Read more ...